ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fostamatinib Tablets Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-22S18543
Home | Market Reports | Health| Pharmacy
Fostamatinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Fostamatinib Tablets Market Research Report 2025

Code: QYRE-Auto-22S18543
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Rigel Pharmaceuticals
Kissei Pharmaceutical
Grifols S A
JW Pharmaceutical Corporation
Medison Pharma Canada

Fostamatinib Tablets Market

The global market for Fostamatinib Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Fostamatinib Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fostamatinib Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fostamatinib Tablets include Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fostamatinib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fostamatinib Tablets.
The Fostamatinib Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fostamatinib Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fostamatinib Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fostamatinib Tablets Market Report

Report Metric Details
Report Name Fostamatinib Tablets Market
Segment by Type
  • 100 mg
  • 150 mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fostamatinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fostamatinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Fostamatinib Tablets Market report?

Ans: The main players in the Fostamatinib Tablets Market are Rigel Pharmaceuticals, Kissei Pharmaceutical, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca

What are the Application segmentation covered in the Fostamatinib Tablets Market report?

Ans: The Applications covered in the Fostamatinib Tablets Market report are Chronic Immune Thrombocytopenia (ITP), Waldenström's Macroglobulinemia, Autoimmune Haemolytic Anaemia, Other

What are the Type segmentation covered in the Fostamatinib Tablets Market report?

Ans: The Types covered in the Fostamatinib Tablets Market report are 100 mg, 150 mg

Recommended Reports

Pharmaceutical Tablets

Oncology Therapies

Blood Disorders

1 Fostamatinib Tablets Market Overview
1.1 Product Definition
1.2 Fostamatinib Tablets by Type
1.2.1 Global Fostamatinib Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 100 mg
1.2.3 150 mg
1.3 Fostamatinib Tablets by Application
1.3.1 Global Fostamatinib Tablets Market Value by Application (2024 VS 2031)
1.3.2 Chronic Immune Thrombocytopenia (ITP)
1.3.3 Waldenström's Macroglobulinemia
1.3.4 Autoimmune Haemolytic Anaemia
1.3.5 Other
1.4 Global Fostamatinib Tablets Market Size Estimates and Forecasts
1.4.1 Global Fostamatinib Tablets Revenue 2020-2031
1.4.2 Global Fostamatinib Tablets Sales 2020-2031
1.4.3 Global Fostamatinib Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fostamatinib Tablets Market Competition by Manufacturers
2.1 Global Fostamatinib Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Fostamatinib Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Fostamatinib Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fostamatinib Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fostamatinib Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fostamatinib Tablets, Product Type & Application
2.7 Global Key Manufacturers of Fostamatinib Tablets, Date of Enter into This Industry
2.8 Global Fostamatinib Tablets Market Competitive Situation and Trends
2.8.1 Global Fostamatinib Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fostamatinib Tablets Players Market Share by Revenue
2.8.3 Global Fostamatinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fostamatinib Tablets Market Scenario by Region
3.1 Global Fostamatinib Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fostamatinib Tablets Sales by Region: 2020-2031
3.2.1 Global Fostamatinib Tablets Sales by Region: 2020-2025
3.2.2 Global Fostamatinib Tablets Sales by Region: 2026-2031
3.3 Global Fostamatinib Tablets Revenue by Region: 2020-2031
3.3.1 Global Fostamatinib Tablets Revenue by Region: 2020-2025
3.3.2 Global Fostamatinib Tablets Revenue by Region: 2026-2031
3.4 North America Fostamatinib Tablets Market Facts & Figures by Country
3.4.1 North America Fostamatinib Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fostamatinib Tablets Sales by Country (2020-2031)
3.4.3 North America Fostamatinib Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fostamatinib Tablets Market Facts & Figures by Country
3.5.1 Europe Fostamatinib Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fostamatinib Tablets Sales by Country (2020-2031)
3.5.3 Europe Fostamatinib Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fostamatinib Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Fostamatinib Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fostamatinib Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Fostamatinib Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fostamatinib Tablets Market Facts & Figures by Country
3.7.1 Latin America Fostamatinib Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fostamatinib Tablets Sales by Country (2020-2031)
3.7.3 Latin America Fostamatinib Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fostamatinib Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Fostamatinib Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fostamatinib Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fostamatinib Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fostamatinib Tablets Sales by Type (2020-2031)
4.1.1 Global Fostamatinib Tablets Sales by Type (2020-2025)
4.1.2 Global Fostamatinib Tablets Sales by Type (2026-2031)
4.1.3 Global Fostamatinib Tablets Sales Market Share by Type (2020-2031)
4.2 Global Fostamatinib Tablets Revenue by Type (2020-2031)
4.2.1 Global Fostamatinib Tablets Revenue by Type (2020-2025)
4.2.2 Global Fostamatinib Tablets Revenue by Type (2026-2031)
4.2.3 Global Fostamatinib Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Fostamatinib Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fostamatinib Tablets Sales by Application (2020-2031)
5.1.1 Global Fostamatinib Tablets Sales by Application (2020-2025)
5.1.2 Global Fostamatinib Tablets Sales by Application (2026-2031)
5.1.3 Global Fostamatinib Tablets Sales Market Share by Application (2020-2031)
5.2 Global Fostamatinib Tablets Revenue by Application (2020-2031)
5.2.1 Global Fostamatinib Tablets Revenue by Application (2020-2025)
5.2.2 Global Fostamatinib Tablets Revenue by Application (2026-2031)
5.2.3 Global Fostamatinib Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Fostamatinib Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Rigel Pharmaceuticals
6.1.1 Rigel Pharmaceuticals Company Information
6.1.2 Rigel Pharmaceuticals Description and Business Overview
6.1.3 Rigel Pharmaceuticals Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Rigel Pharmaceuticals Fostamatinib Tablets Product Portfolio
6.1.5 Rigel Pharmaceuticals Recent Developments/Updates
6.2 Kissei Pharmaceutical
6.2.1 Kissei Pharmaceutical Company Information
6.2.2 Kissei Pharmaceutical Description and Business Overview
6.2.3 Kissei Pharmaceutical Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kissei Pharmaceutical Fostamatinib Tablets Product Portfolio
6.2.5 Kissei Pharmaceutical Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Fostamatinib Tablets Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 JW Pharmaceutical Corporation
6.4.1 JW Pharmaceutical Corporation Company Information
6.4.2 JW Pharmaceutical Corporation Description and Business Overview
6.4.3 JW Pharmaceutical Corporation Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 JW Pharmaceutical Corporation Fostamatinib Tablets Product Portfolio
6.4.5 JW Pharmaceutical Corporation Recent Developments/Updates
6.5 Medison Pharma Canada
6.5.1 Medison Pharma Canada Company Information
6.5.2 Medison Pharma Canada Description and Business Overview
6.5.3 Medison Pharma Canada Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medison Pharma Canada Fostamatinib Tablets Product Portfolio
6.5.5 Medison Pharma Canada Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Fostamatinib Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Fostamatinib Tablets Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fostamatinib Tablets Industry Chain Analysis
7.2 Fostamatinib Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fostamatinib Tablets Production Mode & Process Analysis
7.4 Fostamatinib Tablets Sales and Marketing
7.4.1 Fostamatinib Tablets Sales Channels
7.4.2 Fostamatinib Tablets Distributors
7.5 Fostamatinib Tablets Customer Analysis
8 Fostamatinib Tablets Market Dynamics
8.1 Fostamatinib Tablets Industry Trends
8.2 Fostamatinib Tablets Market Drivers
8.3 Fostamatinib Tablets Market Challenges
8.4 Fostamatinib Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Rigel Pharmaceuticals
Kissei Pharmaceutical
Grifols S A
JW Pharmaceutical Corporation
Medison Pharma Canada
List of Tables
 Table 1. Global Fostamatinib Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Fostamatinib Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Fostamatinib Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Fostamatinib Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Fostamatinib Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Fostamatinib Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Fostamatinib Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Fostamatinib Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Fostamatinib Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Fostamatinib Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Fostamatinib Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Fostamatinib Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fostamatinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fostamatinib Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fostamatinib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Fostamatinib Tablets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Fostamatinib Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Fostamatinib Tablets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Fostamatinib Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Fostamatinib Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Fostamatinib Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Fostamatinib Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Fostamatinib Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Fostamatinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Fostamatinib Tablets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Fostamatinib Tablets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Fostamatinib Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Fostamatinib Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Fostamatinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Fostamatinib Tablets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Fostamatinib Tablets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Fostamatinib Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Fostamatinib Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Fostamatinib Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Fostamatinib Tablets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Fostamatinib Tablets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Fostamatinib Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Fostamatinib Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fostamatinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Fostamatinib Tablets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Fostamatinib Tablets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Fostamatinib Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Fostamatinib Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Fostamatinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Fostamatinib Tablets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Fostamatinib Tablets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Fostamatinib Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Fostamatinib Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Fostamatinib Tablets Sales (K Units) by Type (2020-2025)
 Table 51. Global Fostamatinib Tablets Sales (K Units) by Type (2026-2031)
 Table 52. Global Fostamatinib Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Fostamatinib Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Fostamatinib Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Fostamatinib Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Fostamatinib Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Fostamatinib Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Fostamatinib Tablets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Fostamatinib Tablets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Fostamatinib Tablets Sales (K Units) by Application (2020-2025)
 Table 61. Global Fostamatinib Tablets Sales (K Units) by Application (2026-2031)
 Table 62. Global Fostamatinib Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Fostamatinib Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Fostamatinib Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Fostamatinib Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Fostamatinib Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Fostamatinib Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Fostamatinib Tablets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Fostamatinib Tablets Price (US$/Unit) by Application (2026-2031)
 Table 70. Rigel Pharmaceuticals Company Information
 Table 71. Rigel Pharmaceuticals Description and Business Overview
 Table 72. Rigel Pharmaceuticals Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Rigel Pharmaceuticals Fostamatinib Tablets Product
 Table 74. Rigel Pharmaceuticals Recent Developments/Updates
 Table 75. Kissei Pharmaceutical Company Information
 Table 76. Kissei Pharmaceutical Description and Business Overview
 Table 77. Kissei Pharmaceutical Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Kissei Pharmaceutical Fostamatinib Tablets Product
 Table 79. Kissei Pharmaceutical Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Grifols Fostamatinib Tablets Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. JW Pharmaceutical Corporation Company Information
 Table 86. JW Pharmaceutical Corporation Description and Business Overview
 Table 87. JW Pharmaceutical Corporation Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. JW Pharmaceutical Corporation Fostamatinib Tablets Product
 Table 89. JW Pharmaceutical Corporation Recent Developments/Updates
 Table 90. Medison Pharma Canada Company Information
 Table 91. Medison Pharma Canada Description and Business Overview
 Table 92. Medison Pharma Canada Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Medison Pharma Canada Fostamatinib Tablets Product
 Table 94. Medison Pharma Canada Recent Developments/Updates
 Table 95. AstraZeneca Company Information
 Table 96. AstraZeneca Description and Business Overview
 Table 97. AstraZeneca Fostamatinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AstraZeneca Fostamatinib Tablets Product
 Table 99. AstraZeneca Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Fostamatinib Tablets Distributors List
 Table 103. Fostamatinib Tablets Customers List
 Table 104. Fostamatinib Tablets Market Trends
 Table 105. Fostamatinib Tablets Market Drivers
 Table 106. Fostamatinib Tablets Market Challenges
 Table 107. Fostamatinib Tablets Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fostamatinib Tablets
 Figure 2. Global Fostamatinib Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fostamatinib Tablets Market Share by Type: 2024 & 2031
 Figure 4. 100 mg Product Picture
 Figure 5. 150 mg Product Picture
 Figure 6. Global Fostamatinib Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Fostamatinib Tablets Market Share by Application: 2024 & 2031
 Figure 8. Chronic Immune Thrombocytopenia (ITP)
 Figure 9. Waldenström's Macroglobulinemia
 Figure 10. Autoimmune Haemolytic Anaemia
 Figure 11. Other
 Figure 12. Global Fostamatinib Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Fostamatinib Tablets Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Fostamatinib Tablets Sales (2020-2031) & (K Units)
 Figure 15. Global Fostamatinib Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 16. Fostamatinib Tablets Report Years Considered
 Figure 17. Fostamatinib Tablets Sales Share by Manufacturers in 2024
 Figure 18. Global Fostamatinib Tablets Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Fostamatinib Tablets Players: Market Share by Revenue in Fostamatinib Tablets in 2024
 Figure 20. Fostamatinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Fostamatinib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Fostamatinib Tablets Sales Market Share by Country (2020-2031)
 Figure 23. North America Fostamatinib Tablets Revenue Market Share by Country (2020-2031)
 Figure 24. United States Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Fostamatinib Tablets Sales Market Share by Country (2020-2031)
 Figure 27. Europe Fostamatinib Tablets Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Fostamatinib Tablets Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Fostamatinib Tablets Revenue Market Share by Region (2020-2031)
 Figure 35. China Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Fostamatinib Tablets Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Fostamatinib Tablets Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Fostamatinib Tablets Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Fostamatinib Tablets Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Fostamatinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Fostamatinib Tablets by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Fostamatinib Tablets by Type (2020-2031)
 Figure 54. Global Fostamatinib Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Fostamatinib Tablets by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Fostamatinib Tablets by Application (2020-2031)
 Figure 57. Global Fostamatinib Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 58. Fostamatinib Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Fostamatinib Market Research Report 2024
Gefitinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pazopanib Tablets Market Research Report 2024
Lovastatin Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nilotinib Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Saxagliptin Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orelabrutinib Tablets Market Research Report 2025
Global Dasatinib Tablets Market Research Report 2024
Fluorouracil Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anlotinib Market Research Report 2024
Apixaban Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trametinib Market Research Report 2025
Famotidine Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tucatinib Market Research Report 2025
Cefixime Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Afatinib Market Research Report 2024
Propranolol Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Methotrexate Tablets Market Research Report 2025
Global Indapamide Tablets Market Research Report 2024
Global Ibrutinib Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions